Skip to main content

Published locations for FDA expands ruxolitinib approval to include polycythemia vera

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands ruxolitinib approval to include polycythemia vera

User login

  • Reset your password
  • /content/fda-expands-ruxolitinib-approval-include-polycythemia-vera
  • /familypracticenews/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia
  • /hematologynews/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia-vera
  • /internalmedicinenews/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia
  • /oncologypractice/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia-vera
  • /hematology-oncology/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia
  • /internalmedicine/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia-vera
  • /familymedicine/article/89185/hematology/fda-expands-ruxolitinib-approval-include-polycythemia-vera